Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola

Leistungen

SAC minutes

Summary of Scientific Advisory Committee meetings

Budget templates

Budget templates for awardees to complete

List of communication activities conducted, period 2

List of main communication activities conducted, period 2

List of communication activities conducted, period 4

List of main communication activities conducted, period 4

Project description template

CEPI's project description template for awardees

List of communication activities conducted, period 3

List of main communication activities conducted period 3

3rd periodic report to the EC

3rd periodic report to the EC containing deliverables

2nd periodic report to the EC

2nd periodic report to the EC , containing deliverables for given period

Opening of call online

Validation of the call being opened and made public

Call text

Call text published on the internet provided to the EC

Veröffentlichungen

Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes

Autoren: Corey L. Campbell, Trey K. Snell, Susi Bennett, John H. Wyckoff III, Darragh Heaslip, Jordan Flatt, Emma K. Harris, Daniel A. Hartman, Elena Lian, Brian H. Bird, Mark D. Stenglein, Richard A. Bowen, Rebekah C. Kading
Veröffentlicht in: WILEY ONLINE LIBRARY, Ausgabe Volume 69, Ausgabe 5, 2022, Seite(n) Pages 2621-2633, ISSN 0000-0000
Herausgeber: WILEY ONLINE LIBRARY
DOI: 10.1111/tbed.14415

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera

Autoren: Pierre Roques, Andrea Fritzer, Nathalie Dereuddre-Bosquet, Nina Wressnigg, Romana Hochreiter, Laetitia Bossevot, Quentin Pascal, Fabienne Guehenneux, Annegret Bitzer, Irena Corbic Ramljak, Roger Le Grand, Urban Lundberg, Andreas Meinke
Veröffentlicht in: JCI Insight, Ausgabe Volume 7, Ausgabe14, 2022, ISSN 2379-3708
Herausgeber: JCI Insight
DOI: 10.1172/jci.insight.160173

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo

Autoren: Watson-Jones D, Kavunga-Membo H, Grais RF, Ahuka S, Roberts N, Edmunds WJ, Choi EM, Roberts CH, Edwards T, Camacho A, Lees S, Leyssen M, Spiessens B, Luhn K, Douoguih M, Hatchett R, Bausch DG, Muyembe JJ.
Veröffentlicht in: BMJ Open, Ausgabe 2022, 2022, Seite(n) 12, ISSN 2044-6055
Herausgeber: BMJ Publishing Group
DOI: 10.1136/bmjopen-2021-055596

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Autoren: Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl, Andrea Fritzer, Nicole Bézay, Anton Klingler, Karen Lingnau, Martina Schneider, Urban Lundberg, Andreas Meinke, Julian Larcher-Senn, Irena Čorbic-Ramljak, Susanne Eder-Lingelbach, Katrin Dubischar, Wolfgang Bender.
Veröffentlicht in: The Lancet, Ausgabe Volume 20, Ausgabe 10, 2020, ISSN 0140-6736
Herausgeber: The Lancet Publishing Group
DOI: 10.1016/s1473-3099(20)30238-3

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Autoren: Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl, Robert McMahon, Sebastian Toepfer, Ulrike Fuchs, Romana Hochreiter, Annegret Bitzer, Karin Kosulin, Julian Larcher-Senn, Robert Mader, Katrin Dubischar, Oliver Zoihsl, Juan-Carlos Jaramillo, Susanne Eder-Lingelbach, Vera Buerger, Nina Wressnigg.
Veröffentlicht in: The Lancet, Ausgabe VOLUME 401, ISSUE 10394, 2023, ISSN 0140-6736
Herausgeber: The Lancet Publishing Group
DOI: 10.1016/s0140-6736(23)00641-4

Leistungen

Veröffentlichungen

Diese Seite teilen

Herunterladen